Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

ISPOR’s 2026–2027 HEOR Trends report: The Era of Evidence Judgment

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on...

Genesis Research Group

- PMLiVE

Eisai and Biogen’s subcutaneous Leqembi given FDA Priority Review for early Alzheimer’s

Administering the drug subcutaneously rather than intravenously showed similar clinical benefits for patients

- PMLiVE

Gilead’s Trodelvy plus Keytruda shows positive results in metastatic breast cancer

The combination treatment showed a 35% reduction in the risk of disease progression

- PMLiVE

Sanofi’s amlitelimab shows positive results in atopic dermatitis

Newly released study data shows consistent reductions in disease severity

- PMLiVE

Inizio Evoke appoints Kristin Ryan as Executive VP, AI Transformation & Acceleration

Ryan’s most recent role was Executive VP and US Head of Digital & Innovation at GCI Health

- PMLiVE

Novo Nordisk Foundation gives 736m euro grant to Denmark’s BioInnovation Institute

The funding will run until 2035 and will help the organisation to expand its presence in Europe

- PMLiVE

Book your tickets and join the PM Society for the 40th PM Awards on 20 March 2026

The PM Awards celebrate creativity in pharmaceutical marketing and healthcare communications

- PMLiVE

Inizio Ignite sparks a new era of connected advisory solutions

The new advisory partner brings together Research Partnership, Putnam, Vynamic and STEM

- PMLiVE

PMGroup Worldwide welcomes MAD World Summit

The MAD World Summit is dedicated to transforming workplace culture and employee mental health and well-being

- PMLiVE

Moderna and Merck announce data from melanoma combination therapy study

Skin cancer is one of the most common cancers in the US, with melanoma accounting for the majority of skin cancer deaths

- PMLiVE

Prescient Healthcare Group acquires Uptake

Prescient acquires Uptake, with a focus on exceptional client delivery and impact in the pharmaceutical and biotech industry

- PMLiVE

Skin Health Alliance donates funds to British Skin Foundation to drive research

Part of the funding will be used for research into skin diseases in kidney transplant patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links